表紙
市場調查報告書

台灣的消費者保健品市場

Consumer Health in Taiwan

出版商 Euromonitor International 商品編碼 273893
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
台灣的消費者保健品市場 Consumer Health in Taiwan
出版日期: 2018年01月29日內容資訊: 英文 87 Pages
簡介

由於忙碌的生活方式,飲食不平衡等原因,台灣的消費者保健品市場2014年達成了正成長。由於消費者認為無法馬上改變自己的生活方式和飲食習慣,而尋求維持體形、健康而不生病的產品。

本報告提供台灣的消費者保健品 (一般用醫藥品) 市場相關分析、整體結構、趨勢,再加上主要企業簡介 (企業概要、產業策略、競爭力、產業實際成果等)、各產品市場趨勢、競爭力、未來展望等調查評估。

台灣的消費者健康市場:產業概要

  • 摘要整理
    • 消費者健康市場的持續成長 (2014年)
    • 維他命、補充品變成最大的類別
    • 直銷型企業主導市場
    • 藥局在銷售消費者保健品產品上也發揮重要作用
    • 今後順利的市場成長預測
  • 主要的趨勢與發展
    • 國民保險制度妨礙OTC (一般藥) 市場成長
    • 國內企業的維他命、補充品的進一步供給
    • 運動營養補充品、體重管理產品,在特定群組之間日益流行
  • 市場資料
  • 附錄
    • 成藥的登記與分類
    • 維他命、補充品的法規與分類
    • 自我治療與預防藥
    • 轉換至成藥
  • 資訊來源

企業簡介

  • Cerebos (Taiwan) Ltd
  • Grape King Enterprise Inc
  • Sanyo Pharmaceutical Co Ltd
  • Singhar Pharmaceutical Co Ltd
  • Taiwan Sugar Corp

※以下分類為分冊販售。價格與內容請洽詢聯絡處。

調查類別

  • 成人用口腔保健用品
  • 止痛藥
  • 咳嗽、感冒、過敏 (花粉症) 治療藥
  • 藥用皮膚保養品用品
  • 消化劑
  • 眼睛保健品用品
  • NRT (尼古丁替代療法) 戒煙輔助劑
  • 創傷護理用品
  • 運動營養補充品
  • 維他命、補充品 (營養補充品)
  • 體重管理產品
  • 藥草/傳統產品

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: CHTW

As part of its bid to encourage responsible self-medication, in January 2015 the Taiwan FDA announced plans to switch 13 medicines. Some of these switches are from Rx to OTC status, while some involve widening the retail distribution from chemists/pharmacies and drugstores/parapharmacies. However, these plans immediately met with opposition from the country's medical community, with representatives of the Taiwan Medical Association citing the dangers posed to public health from self-medication a...

Euromonitor International's Consumer Health in Taiwan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. Forecasts to 2022 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

Euromonitor International

January 2018

LIST OF CONTENTS AND TABLES

Executive Summary

Pending OTC Switches Remain in the Pipeline Due To Medical Community Opposition

Increasingly Busy Urban Lifestyles Continue To Impact Sales in Consumer Health

Drugstores/parapharmacies Private Label Lines Compete Against International Brands

the Leading Distribution Channels Underline Their Strength With Positive Growth

the Rise of Self-medication Set To Bolster Growth Rates in OTC Consumer Health

Market Indicators

  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 2 Life Expectancy at Birth 2012-2017

Market Data

  • Table 3 Sales of Consumer Health by Category: Value 2012-2017
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 5 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  • Table 8 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

    • Summary 1 Research Sources

Headlines

Prospects

Suspicion Surrounding Systemic Analgesics Set To Continue Suppressing Growth

Slower Sales Growth Ahead for Analgesics

Powder Drinks Likely To Be One Format To Benefit From Declining Popularity of Tablets

Competitive Landscape

Leading Player GlaxoSmithKline Remains Well Out in Front

Topical Analgesics/anaesthetic Brands Round Out the Top Five Names in Analgesics

Advertising Campaigns Remain Important, With Doctors Often Featured Prominently

Category Data

  • Table 12 Sales of Analgesics by Category: Value 2012-2017
  • Table 13 Sales of Analgesics by Category: % Value Growth 2012-2017
  • Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  • Table 15 NBO Company Shares of Analgesics: % Value 2013-2017
  • Table 16 LBN Brand Shares of Analgesics: % Value 2014-2017
  • Table 17 Forecast Sales of Analgesics by Category: Value 2017-2022
  • Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022

Prospects

Headlines

Prospects

Busier Schedules and More Intense Work Pressures Set To Support Sales Growth

Slower Growth Projections Related To the Shift Towards Preventative Healthcare

the Rising Incidence of Allergies and Possible Rx-otc Switches To Support Growth

Competitive Landscape

GlaxoSmithKline Once Again the Strong Leader

Combination Products Dominate the Leading Brands

Differences Remain Between the Products Offered by Local and International Players

Category Data

  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
  • Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
  • Table 21 Sales of Decongestants by Category: Value 2012-2017
  • Table 22 Sales of Decongestants by Category: % Value Growth 2012-2017
  • Table 23 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
  • Table 24 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
  • Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
  • Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022

Headlines

Prospects

High Incidence of Skin Problems Set To Continue Supporting Sales of Dermatologicals

Holistic Understanding of Skin Health Set To Contribute To Slower Sales Growth

Medicated Shampoos and Topical Antifungals Set for the Most Dynamic Growth

Competitive Landscape

International Medicated Shampoos and Topical Antifungals Brands Lead Sales in Dermatologicals

Leading Companies and Brands Remain at An Advantage Over Their Smaller Rivals

Pending Regulatory Changes Could Alter the Landscape in Topical Antifungals

Category Data

  • Table 27 Sales of Dermatologicals by Category: Value 2012-2017
  • Table 28 Sales of Dermatologicals by Category: % Value Growth 2012-2017
  • Table 29 NBO Company Shares of Dermatologicals: % Value 2013-2017
  • Table 30 LBN Brand Shares of Dermatologicals: % Value 2014-2017
  • Table 31 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
  • Table 32 Forecast Sales of Dermatologicals by Category: Value 2017-2022
  • Table 33 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022

Headlines

Prospects

Emerging Lifestyle Trends Set To Remain Favourable for Sales of Digestive Remedies

Widespread Concerns Over the Safety of Foodservice Likely To Supress Growth Rates

Pending Rx-otc Switches Have the Potential To Strongly Support Sales Growth

Competitive Landscape

Wakamoto Pharmaceutical Co Holds the Leading Position

Major Global Manufacturers Relatively Under-represented in Digestive Remedies

Domestic Companies Set To Regroup After Ingredient Audits

Category Data

  • Table 34 Sales of Digestive Remedies by Category: Value 2012-2017
  • Table 35 Sales of Digestive Remedies by Category: % Value Growth 2012-2017
  • Table 36 NBO Company Shares of Digestive Remedies: % Value 2013-2017
  • Table 37 LBN Brand Shares of Digestive Remedies: % Value 2014-2017
  • Table 38 Forecast Sales of Digestive Remedies by Category: Value 2017-2022
  • Table 39 Forecast Sales of Digestive Remedies by Category: % Value Growth 2017-2022

Headlines

Prospects

Increased Screen Time Set To Support Demand for Eye Care During the Forecast Period

Slower Growth Set To Be Due To Rising Preference for Preventing Eye Strain

the OTC Switch for Allergy Eye Care Drug Ketotifen Remains on Hold

Competitive Landscape

Mentholatum Remains the Leading Eye Care Company With Its Brand V Rohto

International Players Have the Advantage of More Diverse Product Portfolios

the Anticipated Entry of Allergy Eye Care Set To Broaden the Competitive Landscape

Category Data

  • Table 40 Sales of Eye Care by Category: Value 2012-2017
  • Table 41 Sales of Eye Care by Category: % Value Growth 2012-2017
  • Table 42 Sales of Standard Eye Care by Format: % Value 2012-2017
  • Table 43 Sales of Standard Eye Care by Positioning: % Value 2012-2017
  • Table 44 NBO Company Shares of Eye Care: % Value 2013-2017
  • Table 45 LBN Brand Shares of Eye Care: % Value 2014-2017
  • Table 46 Forecast Sales of Eye Care by Category: Value 2017-2022
  • Table 47 Forecast Sales of Eye Care by Category: % Value Growth 2017-2022

Headlines

Prospects

Progressive Anti-smoking Laws Set To Continue Encouraging Many Smokers To Quit

Slumping Sales Due To Fewer Smokers Overall and Fewer Smokers Wanting To Quit

the Availability of Subsidised Nrt Smoking Cessation Aids Through Institutional Channels Set To Continue Harming OTC Sales

Competitive Landscape

Johnson & Johnson Dominates A Consolidated Field of Just Three Players

Competition Remains Limited Among A Very Consolidated Field of Just Three Players

Falling Smoking Prevalence and the Availability of Subsidised Nrt Likely To Discourage New Entrants

Category Indicators

  • Table 48 Number of Smokers by Gender 2012-2017

Category Data

  • Table 49 Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
  • Table 50 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
  • Table 51 Sales of NRT Gum by Flavour: % Value 2012-2017
  • Table 52 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2013-2017
  • Table 53 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2014-2017
  • Table 54 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
  • Table 55 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022

Headlines

Prospects

Wound Care Set To for A Moderately Positive Performance

Slower Growth Expected in the Category During the Forecast Period

Private Label Likely To Become A Stronger Presence in Wound Care

Competitive Landscape

3m Remains the Category's Only Major Branded Player, Dominating Sales in 2017

Private Label Set To Benefit From Its Major Advantage: Lower Prices

Private Label Wound Care Products Set To Become More Sophisticated

Category Data

  • Table 56 Sales of Wound Care by Category: Value 2012-2017
  • Table 57 Sales of Wound Care by Category: % Value Growth 2012-2017
  • Table 58 NBO Company Shares of Wound Care: % Value 2013-2017
  • Table 59 LBN Brand Shares of Wound Care: % Value 2014-2017
  • Table 60 Forecast Sales of Wound Care by Category: Value 2017-2022
  • Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2017-2022

Headlines

Prospects

Emerging Lifestyles Trends Favourable for Growth in Sports Nutrition

Slower Growth Expected for Sports Nutrition

Retail Distribution Set To Continue Influencing Sales of Sports Nutrition

Competitive Landscape

Abbott Laboratories Maintains Its Leading Position Despite Strong Competition

International Brands Maintain Strong Advantages

the Shift Towards Internet Retailing Is Eroding the Positions of the Leading Players

Category Data

  • Table 62 Sales of Sports Nutrition by Category: Value 2012-2017
  • Table 63 Sales of Sports Nutrition by Category: % Value Growth 2012-2017
  • Table 64 NBO Company Shares of Sports Nutrition: % Value 2013-2017
  • Table 65 LBN Brand Shares of Sports Nutrition: % Value 2014-2017
  • Table 66 Forecast Sales of Sports Nutrition by Category: Value 2017-2022
  • Table 67 Forecast Sales of Sports Nutrition by Category: % Value Growth 2017-2022

Headlines

Prospects

Prevailing Health Trends Likely To Influence Growth Trends in Dietary Supplements

Consistently Positive Growth To Remain A Theme of Dietary Supplements

Innovation Set To Remain An Essential Element of Company Strategies

Competitive Landscape

Amway Maintains Its Leading Position

International Companies Continue To Dominate Sales

Direct Selling Players Remain A Strong Force in Dietary Supplements

Category Data

  • Table 68 Sales of Dietary Supplements by Category: Value 2012-2017
  • Table 69 Sales of Dietary Supplements by Category: % Value Growth 2012-2017
  • Table 70 Sales of Dietary Supplements by Positioning: % Value 2012-2017
  • Table 71 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2012-2017
  • Table 72 NBO Company Shares of Dietary Supplements: % Value 2013-2017
  • Table 73 LBN Brand Shares of Dietary Supplements: % Value 2014-2017
  • Table 74 Forecast Sales of Dietary Supplements by Category: Value 2017-2022
  • Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2017-2022

Headlines

Prospects

Multivitamins Set To Lead Growth Over the Forecast Period

Busy Lifestyles Set To Support Demand for Vitamins

Age Segmentation Likely To Remain at the Forefront of Brand Strategies

Competitive Landscape

Pfizer Maintains A Very Strong Position, Offering Several Vitamins Brands

Direct Selling Companies Maintain A Strong Presence in Vitamins

International Players Set To Remain Dominant

Category Data

  • Table 76 Sales of Vitamins by Category: Value 2012-2017
  • Table 77 Sales of Vitamins by Category: % Value Growth 2012-2017
  • Table 78 Sales of Multivitamins by Positioning: % Value 2012-2017
  • Table 79 NBO Company Shares of Vitamins: % Value 2013-2017
  • Table 80 LBN Brand Shares of Vitamins: % Value 2014-2017
  • Table 81 Forecast Sales of Vitamins by Category: Value 2017-2022
  • Table 82 Forecast Sales of Vitamins by Category: % Value Growth 2017-2022

Headlines

Prospects

Slower Growth Expected in Weight Management and Wellbeing

Trends in Weight Loss Set To Influence Sales Trends in Various Categories

Emerging Consumer Trends Likely To Influence Company Strategies

Competitive Landscape

Herbalife Remains the Outstanding Player in Weight Management and Wellbeing

Direct Selling Companies Maintain Their Strong Positions

Local Presence Confined Mainly To Slimming Teas and Weight Loss Supplements

Category Data

  • Table 83 Sales of Weight Management and Wellbeing by Category: Value 2012-2017
  • Table 84 Sales of Weight Management and Wellbeing by Category: % Value Growth 2012-2017
  • Table 85 NBO Company Shares of Weight Management and Wellbeing: % Value 2013-2017
  • Table 86 LBN Brand Shares of Weight Management and Wellbeing: % Value 2014-2017
  • Table 87 Forecast Sales of Weight Management and Wellbeing by Category: Value 2017-2022
  • Table 88 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022

Headlines

Prospects

Herbal/traditional Products To Continue Benefiting From Their Natural and Holistic Image

Diminishing Consumer Base Set To Suppress Growth Rates

Catering To Diverse Needs Likely To Be Key To Success

Competitive Landscape

Sanyo Pharmaceutical Co Maintains Its Strong Leading Position

Innovative New Products Continue To Prove Popular Among Consumers

Local Players Remain Dominant

Category Data

  • Table 89 Sales of Herbal/Traditional Products by Category: Value 2012-2017
  • Table 90 Sales of Herbal/Traditional Products by Category: % Value Growth 2012-2017
  • Table 91 NBO Company Shares of Herbal/Traditional Products: % Value 2013-2017
  • Table 92 LBN Brand Shares of Herbal/Traditional Products: % Value 2014-2017
  • Table 93 Forecast Sales of Herbal/Traditional Products by Category: Value 2017-2022
  • Table 94 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022

Headlines

Prospects

Narrow Range of Products Set To Continue Limiting Sales

Paediatric Vitamins and Dietary Supplements Set To Continue Dominating Sales

the Cautious Approach of Parents To Children's Health To Remain A Barrier To Growth

Competitive Landscape

Pfizer Still on Top Due To the Strength of Its Leading Multivitamins Brand Centrum

Three Players Dominate Sales in Paediatric Cough/cold Remedies

New Entrants Unlikely To Be Seen During the Forecast Period

Category Data

  • Table 95 Sales of Paediatric Consumer Health by Category: Value 2012-2017
  • Table 96 Sales of Paediatric Consumer Health by Category: % Value Growth 2012-2017
  • Table 97 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2014-2017
  • Table 98 NBO Company Shares of Paediatric Consumer Health: % Value 2013-2017
  • Table 99 LBN Brand Shares of Paediatric Consumer Health: % Value 2014-2017
  • Table 100 Forecast Sales of Paediatric Consumer Health by Category: Value 2017-2022
  • Table 101 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Back to Top